These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

419 related articles for article (PubMed ID: 33278505)

  • 21. Good riddance to dopamine: roles for the dopamine transporter in synaptic function and dopamine-associated brain disorders.
    Gowrishankar R; Hahn MK; Blakely RD
    Neurochem Int; 2014 Jul; 73():42-8. PubMed ID: 24231471
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gestational restraint stress and the developing dopaminergic system: an overview.
    Baier CJ; Katunar MR; Adrover E; Pallarés ME; Antonelli MC
    Neurotox Res; 2012 Jul; 22(1):16-32. PubMed ID: 22215534
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dopaminergic Perturbation in the Aetiology of Neurodevelopmental Disorders.
    Ijomone OK; Oria RS; Ijomone OM; Aschner M; Bornhorst J
    Mol Neurobiol; 2024 Aug; ():. PubMed ID: 39110391
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mean Diffusivity in the Dopaminergic System and Neural Differences Related to Dopaminergic System.
    Takeuchi H; Kawashima R
    Curr Neuropharmacol; 2018; 16(4):460-474. PubMed ID: 29119929
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dopaminergic dysbalance in distinct basal ganglia neurocircuits: implications for the pathophysiology of Parkinson's disease, schizophrenia and attention deficit hyperactivity disorder.
    Mehler-Wex C; Riederer P; Gerlach M
    Neurotox Res; 2006 Dec; 10(3-4):167-79. PubMed ID: 17197367
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Crosstalk of metabolic factors and neurogenic signaling in adult neurogenesis: Implication of metabolic regulation for mental and neurological diseases.
    Gao C; Wang Q; Chung SK; Shen J
    Neurochem Int; 2017 Jun; 106():24-36. PubMed ID: 28188802
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Role of the endocannabinoid system in neurological disorders.
    Zou M; Li D; Li L; Wu L; Sun C
    Int J Dev Neurosci; 2019 Aug; 76():95-102. PubMed ID: 30858029
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dopaminergic contribution to the regulation of emotional perception.
    Salgado-Pineda P; Delaveau P; Blin O; Nieoullon A
    Clin Neuropharmacol; 2005; 28(5):228-37. PubMed ID: 16239763
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Perinatal hypoxia as a risk factor for psychopathology later in life: the role of dopamine and neurotrophins.
    Giannopoulou I; Pagida MA; Briana DD; Panayotacopoulou MT
    Hormones (Athens); 2018 Mar; 17(1):25-32. PubMed ID: 29858855
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Progress and roadblocks in the search for brain-based biomarkers of autism and attention-deficit/hyperactivity disorder.
    Uddin LQ; Dajani DR; Voorhies W; Bednarz H; Kana RK
    Transl Psychiatry; 2017 Aug; 7(8):e1218. PubMed ID: 28892073
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Is dopamine transporter-mediated dopaminergic signaling in the retina a noninvasive biomarker for attention-deficit/ hyperactivity disorder? A study in a novel dopamine transporter variant Val559 transgenic mouse model.
    Dai H; Jackson CR; Davis GL; Blakely RD; McMahon DG
    J Neurodev Disord; 2017 Dec; 9(1):38. PubMed ID: 29281965
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The interplay of dopamine metabolism abnormalities and mitochondrial defects in the pathogenesis of schizophrenia.
    Xu H; Yang F
    Transl Psychiatry; 2022 Nov; 12(1):464. PubMed ID: 36344514
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The dopaminergic system dynamic in the time perception: a review of the evidence.
    Marinho V; Oliveira T; Rocha K; Ribeiro J; Magalhães F; Bento T; Pinto GR; Velasques B; Ribeiro P; Di Giorgio L; Orsini M; Gupta DS; Bittencourt J; Bastos VH; Teixeira S
    Int J Neurosci; 2018 Mar; 128(3):262-282. PubMed ID: 28950734
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The control of responsiveness in ADHD by catecholamines: evidence for dopaminergic, noradrenergic and interactive roles.
    Oades RD; Sadile AG; Sagvolden T; Viggiano D; Zuddas A; Devoto P; Aase H; Johansen EB; Ruocco LA; Russell VA
    Dev Sci; 2005 Mar; 8(2):122-31. PubMed ID: 15720370
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [A neurocomputational model for the thalamocortical loop: towards a better understanding of attention deficit hyperactivity disorder].
    Madureira DQ; de Carvalho LA; Cheniaux E
    Arq Neuropsiquiatr; 2007 Dec; 65(4A):1043-9. PubMed ID: 18094875
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Transient activation of dopaminergic neurons during development modulates visual responsiveness, locomotion and brain activity in a dopamine ontogeny model of schizophrenia.
    Calcagno B; Eyles D; van Alphen B; van Swinderen B
    Transl Psychiatry; 2013 Jan; 3(1):e206. PubMed ID: 23299394
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Human brain organogenesis: Toward a cellular understanding of development and disease.
    Kelley KW; Pașca SP
    Cell; 2022 Jan; 185(1):42-61. PubMed ID: 34774127
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Endogenous Retroviruses Activity as a Molecular Signature of Neurodevelopmental Disorders.
    Balestrieri E; Matteucci C; Cipriani C; Grelli S; Ricceri L; Calamandrei G; Vallebona PS
    Int J Mol Sci; 2019 Nov; 20(23):. PubMed ID: 31801288
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Emerging Roles of BAI Adhesion-GPCRs in Synapse Development and Plasticity.
    Duman JG; Tu YK; Tolias KF
    Neural Plast; 2016; 2016():8301737. PubMed ID: 26881134
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Insights from animal models on insulin signalling disturbances and related diseases in neurological and mental conditions.
    Slattery DA
    Neurosci Biobehav Rev; 2024 Jun; 161():105694. PubMed ID: 38678735
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.